Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Lung Cancer Screening: New Perspective and Challenges in Europe.

Tytuł:
Lung Cancer Screening: New Perspective and Challenges in Europe.
Autorzy:
Van Meerbeeck JP; Department of Thoracic Oncology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.
O'Dowd E; Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
Ward B; European Respiratory Society, Advocacy Department, 1000 Brussels, Belgium.
Van Schil P; Department of Thoracic and Vascular Surgery, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.
Snoeckx A; Department of Radiology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.
Źródło:
Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
References:
Cancer Prev Res (Phila). 2022 Jan;15(1):37-44. (PMID: 34580085)
Lancet Oncol. 2017 Nov;18(11):1523-1531. (PMID: 29055736)
J Natl Cancer Inst. 2020 May 1;112(5):466-479. (PMID: 31566216)
Int J Cancer. 2018 Jan 1;142(1):44-56. (PMID: 28940326)
PLoS Med. 2017 Apr 4;14(4):e1002277. (PMID: 28376113)
JAMA Oncol. 2021 Dec 01;7(12):1833-1842. (PMID: 34673885)
Int J Cancer. 2020 Mar 15;146(6):1503-1513. (PMID: 31162856)
Lancet Reg Health Eur. 2021 Sep 11;10:100179. (PMID: 34806061)
Invest Radiol. 2012 Aug;47(8):457-61. (PMID: 22717879)
Radiology. 2017 Sep;284(3):630-644. (PMID: 28825886)
BMJ Open. 2015 Jul 14;5(7):e008254. (PMID: 26173719)
Lung Cancer. 2021 Nov;161:136-140. (PMID: 34583222)
BMJ. 2017 Feb 8;356:j347. (PMID: 28179230)
Br J Cancer. 2008 Jan 29;98(2):270-6. (PMID: 18087271)
N Engl J Med. 2011 Aug 4;365(5):395-409. (PMID: 21714641)
Lancet Oncol. 2013 Dec;14(13):e591-600. (PMID: 24275132)
BMJ Open. 2020 Sep 10;10(9):e037075. (PMID: 32912947)
N Engl J Med. 2013 Feb 21;368(8):728-36. (PMID: 23425165)
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):411-420. (PMID: 28137752)
Ann Intern Med. 2012 Aug 21;157(4):242-50. (PMID: 22910935)
Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975. (PMID: 31825647)
Am J Prev Med. 2019 Aug;57(2):250-255. (PMID: 31248742)
Clin Lung Cancer. 2020 May;21(3):e206-e211. (PMID: 32001154)
Ann Intern Med. 2018 Jul 3;169(1):10-19. (PMID: 29800127)
N Engl J Med. 2020 Feb 6;382(6):503-513. (PMID: 31995683)
Eur J Cancer. 2020 Aug;135:121-129. (PMID: 32563896)
J Thorac Oncol. 2019 Oct;14(10):1732-1742. (PMID: 31260833)
Thorax. 2020 Oct;75(10):908-912. (PMID: 32759387)
Eur Radiol. 2007 Jun;17(6):1474-82. (PMID: 17206426)
J Thorac Oncol. 2017 Aug;12(8):1210-1222. (PMID: 28499861)
Thorax. 2016 Feb;71(2):161-70. (PMID: 26645413)
Lung Cancer. 2018 Oct;124:189-198. (PMID: 30268459)
Thorax. 2015 Aug;70 Suppl 2:ii1-ii54. (PMID: 26082159)
Radiology. 2017 Jul;284(1):228-243. (PMID: 28240562)
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S95-S105. (PMID: 31211110)
N Engl J Med. 2014 Nov 6;371(19):1793-802. (PMID: 25372087)
Ann Oncol. 2019 Jul 1;30(7):1162-1169. (PMID: 30937431)
Mayo Clin Proc. 2019 Aug;94(8):1623-1640. (PMID: 31378236)
J Thorac Oncol. 2016 Jan;11(1):21-9. (PMID: 26762736)
Lung Cancer. 2018 Dec;126:119-124. (PMID: 30527175)
BMJ Open. 2020 Sep 10;10(9):e037086. (PMID: 32912948)
NPJ Prim Care Respir Med. 2021 Jun 7;31(1):36. (PMID: 34099737)
Contributed Indexing:
Keywords: computed tomography; lung cancer; management; screening
Entry Date(s):
Date Created: 20220514 Latest Revision: 20220716
Update Code:
20240105
PubMed Central ID:
PMC9099920
DOI:
10.3390/cancers14092343
PMID:
35565472
Czasopismo naukowe
Randomized-controlled trials have shown clear evidence that lung cancer screening with low-dose CT in a high-risk population of current or former smokers can significantly reduce lung-cancer-specific mortality by an inversion of stage distribution at diagnosis. This paper will review areas in which there is good or emerging evidence and areas which still require investment, research or represent implementation challenges. The implementation of population-based lung cancer screening in Europe is variable and fragmented. A number of European countries seem be on the verge of implementing lung cancer screening, mainly through the implementation of studies or trials. The cost and capacity of CT scanners and radiologists are considered to be the main hurdles for future implementation. Actions by the European Commission, related to its published Europe's Beating Cancer Plan and the proposal to update recommendations on cancer screening, could be an incentive to help speed up its implementation.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies